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Background: Dengue, a mosquito-borne viral infection caused by one of the four dengue virus (DENV) serotypes
(DENV-1 to 4), replicate alternately on the mosquito vector and human host and are responsible for infections
throughout tropical and subtropical regions of the world. In Brazil, the disease has become a major public health
problem and the introduction of DENV-3 in 2000 in Rio de Janeiro (RJ) was associated with severe dengue
epidemics. The potential emergence of strains associated with severe disease highlights the need for the
surveillance of DENV in human host and vectors.
Methods: Aiming to contribute for DENV phylogenetic and vector-virus-human host studies, we sequenced the
entire genome of one DENV-3 isolated from naturally infected Aedes aegypti from RJ in 2001 and characterized the
3’ UTR from strains isolated from mosquitoes and humans. Mosquitoes were pooled and submitted to virus
isolation in Ae. albopictus C6/36 cells and the infecting serotype was identified by immunofluorescence using
type-specific monoclonal antibody. Sequence analysis was performed using BioEdit software, the multiple
alignments were performed using CLUSTAL W and the phylogenetic analysis by MEGA 5, using the
Neighbor-joining method. Secondary structure prediction was performed by using the MFOLD program.
Results: Exclusive substitutions and a substitution leading to a stop codon on the NS5 gene were observed in the
DENV-3 isolated from a naturally infected Ae. aegypti and fully sequenced. As an 8- nucleotides deletion was
observed within the 11- nucleotides (nts) insertion on the variable region (VR) from the 3′UTR in this isolate, we
further sequenced other DENV-3 from both mosquitoes and humans. The majority of DENV-3 from RJ analyzed
were characterized by the 11-nts insertion in the VR of the 3′UTR, despite the observation of strains carrying the
8-nts deletion. The latter presented similar secondary structures, however not all strains presenting the 11-nts
insertion were similar in the predicted secondary structure.
Conclusions: The phylogeny based on the analysis of the complete genome and 3′UTR characterized the DENV-3
isolated from both vector and human host as belonging to Genotype III (GIII), despite the differences observed on
the 3’ UTR. Further studies are needed to address the role of those mutations in the transmission of the different
viral populations and vector competence.
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Dengue is a mosquito-borne viral infection caused by one
of the four dengue virus serotypes (DENV-1 to 4), belonging
to genus Flavivirus, family Flaviviridae. The viruses repli-
cate alternately on the mosquito vector, mainly (Ae. aegypti)
and human host and are responsible for infections through-
out tropical and subtropical regions of the world [1,2].
The rapid global spread of the four DENV serotypes in
the last 50 years resulted in the dispersal of genotypes
associated with increased disease severity [3]. In Brazil,
dengue has been a major public health problem since
DENV-1 introduction and spread in 1986 [4], however the
introduction of the genotype III of DENV-3, in December
2000, in Nova Iguaçu, State of Rio de Janeiro (RJ), caused
one of the most severe epidemics reported in the country
in 2002 [5-7]. Despite the co-circulation of DENV-1,
DENV-2 and DENV-3 in that area, DENV-3 was the only
serotype detected in pools of Ae. aegypti during an ento-
mological surveillance performed [8].
Sequencing of distinct DENV genomic regions has iden-
tified five genotypes for DENV-3: Genotypes I to III (GI to
GIII) which are responsible for most DENV-3 human
infections and have been associated with both dengue fever
(DF) and dengue haemorrhagic fever (DHF) epidemics in
Southeast Asia, Indian Subcontinent, South Pacific and
East Africa and Americas, and Genotypes IV and V (GIV
and GV) which were not associated with DHF epidemics
and are only represented by few early sequences from
Americas, South Pacific and Asia [9-13].
The DENV genome is composed by a positive single-
stranded RNA of approximately 11 kb in length with an
open reading frame encoding for the viral polyprotein,
which is cleaved into three structural proteins (C, prM
and E) and seven non-structural proteins (NS1, NS2A,
NS2B, NS3, NS4 and NS5) flanked by 5′ and 3′ untrans-
lated regions (UTRs) of about 100 and 400 nucleotides,
respectively [1]. The flaviviruses UTRs are predicted to
form secondary stem-loop (SL) structures, which are highly
conserved and play a role in viral replication [14-18].
According to predicted secondary structures, the DENV
3′UTR can be divided into three domains [18]. The
domain I, which is located immediately after the NS5 stop
codon, is considered the most variable region (VR) within
the viral 3′UTR, as it shows large heterogeneity in both
length and nucleotide sequences [19-21]. Mutations and
deletions within these regions may alter infectivity and
reduce efficiency of viral replication [22,23] and differences
between strains in these regions may correlate with DENV
virulence and pathogenicity [24-27]. Furthermore, deletions
and nucleotide variations were also described in the VR
within the same serotype [28-30]. Domain II is of moderate
conservation, comprising several hairpins motifs and
where conserved sequence (CS2) and repeated CS2
(RCS2) are present. Domain III is the most conservedregion of the 3′UTR with CS1 followed by a terminal
stem-loop (3′SL) [18].
Here, aiming to contribute for the studies on human
host-virus-vector interactions, we fully sequenced the gen-
ome of one DENV-3 isolated from naturally infected field-
caught mosquitoes in RJ and characterized the viral 3′UTR
in comparison to other sequenced DENV-3 isolated from
naturally infected mosquitoes and human hosts.
Material and Methods
Ethical Statement
All human DENV-3 strains belong to a previously ga-
thered collection from the Laboratory of Flavivirus, IOC/
FIOCRUZ, RJ, Brazil obtained from acute phase human
serum through the passive surveillance system from an
ongoing Project approved by resolution number CSN196/
96 from the Oswaldo Cruz Foundation Ethical Committee
in Research (CEP 274/05), Ministry of Health, Brazil.
Ae. aegypti examined in this study were collected by
the staff of the Dengue Control State Program for the
determination of house infestation index, virological
and entomological surveillance. No special permission
or written consent is required for house entrance for
mosquito collection and larval site treatment.
Viral strains
The DENV-3 strains isolated from Ae. aegypti adult mos-
quitoes (n=4) and human hosts (n=10) naturally infected
in RJ were collected from epidemics occurred from 2001
to 2008. The first Brazilian DENV-3 strain (BR74886/02)
isolated from a human fatal case fully sequenced [31] was
used for comparison purposes and detailed information on
the strains is provided on Table 1.
DENV-3 human cases
From 2001 to 2008, the Laboratory of Flavivirus, as a
Regional Reference Laboratory for the Brazilian Ministry
of Health, received a total of 16,185 dengue suspected cases
for routine diagnosis. Virus isolation was attempted in
9,405 cases and DENV-3 was the infecting serotype in
52.8% of the positive isolates. The samples analyzed in this
study were chosen randomly and representative of each
year, during and after the 2002 epidemic in RJ.
DENV-3 entomological surveillances
The three DENV-3 strains isolated (BR73354/01,
BR73356/01 and BR73636/01) in 2001 from naturally
infected Ae. aegypti adult mosquitoes used in this
study were collected during an entomological survey
performed in 35 districts of Nova Iguaçu, RJ, from
July 2000 to June 2001. The other DENV-3 strain
(BR81200/06) was isolated from naturally infected Ae.
aegypti adult mosquitoes collected during an entomological
survey conducted on 7 districts with different infestation
Table 1 Brazilian DENV-3 isolated from naturally infected vectors and human cases analyzed in this study
Strain Origin State* Year of isolation Source GenBank accession number Sequence analyzed Reference
BR73354/01 RJ 2001 Mosquitoes FJ177308 Complete genome This study
BR73356/01 RJ 2001 Mosquitoes JN383345 3′UTR This study
BR73636/01 RJ 2001 Mosquitoes JN383346 3′UTR This study
BR81200/06 RJ 2006 Mosquitoes JN383344 3′UTR This study
BR70562/01 RJ 2002 Human serum JN380902 3′UTR This study
BR74792/02 RJ 2002 Human serum JN380899 3′UTR This study
BR74916/02 RJ 2002 Human serum JN380901 3′UTR This study
BR74947/02 RJ 2002 Human serum JN380904 3′UTR This study
BR77515/03 RJ 2003 Human serum JN380900 3′UTR This study
BR78969/04 RJ 2004 Human serum JN380905 3′UTR This study
BR80740/05 RJ 2005 Human serum JN380906 3′UTR This study
BR80996/06 RJ 2006 Human serum JN380903 3′UTR This study
BR83904/07 RJ 2007 Human serum JN380898 3′UTR This study
BR072/08 RJ 2008 Human serum JN380907 3′UTR This study
BR74886/02 RJ 2002 Human liver AY679147 Complete genome Miagostovich et al., 2006
*RJ: Rio de Janeiro.
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Janeiro, RJ, from March 2005 to February 2006. Briefly,
adult mosquitoes were collected twice a week, alternately in
the morning and in the afternoon with manual and battery
backpack aspirators and with nets, both indoor and in the
yards and gardens, close to the dwellings. Mosquitoes were
identified using a key as previously described [32], pooled
according to gender, date, district of collection and stored
in liquid nitrogen at the same day of collection. A total of
503 Ae. aegypti mosquitoes (352 females and 151 males)
collected in 2000–2001 and 874 Ae. aegypti females
collected in 2005–2006 were pooled (74 pools of 9–17
mosquitoes/pool in 2000–2001 and 27 pools of 2–10
mosquitoes/pool, jn 2005–2006) and all pools were submit-
ted for virus isolation. Only positive pools were submitted
to RT-PCR. for DENV serotype confirmation.
Preparation of vectors
Mosquitoes’ pools were macerated in 1 ml of Leibovitz
L-15 medium (Sigma) plus antibiotics (penicillin-strepto-
mycin, 10,000 units - Invitrogen) and centrifuged (6,000
rpm at 4°C for 30 min). Supernatant was transferred to an
Eppendorf tube containing 100 mL of streptomycin / fungi-
zone and penicillin, kept in an ice bath for 1 hour and
centrifuged (3,000 rpm at 4°C for 15 min). Supernatant was
transferred to an Eppendorf tube containing 0.3ml of fetal
calf serum (Invitrogen) and frozen (−70°C).
Virus isolation
Virus isolation was performed by inoculation into mono-
layers of C6/36 Aedes albopictus cells [33] in Leibovitz L-15medium (Sigma) supplemented with 2% fetal calf serum
(Invitrogen) and 0.2 mM of nonessential amino acids
(Invitrogen). Cells were incubated at 28°C for 5 to 7 days
and observed for cytopathic effects. Isolates were identi-
fied by indirect fluorescent antibody test (IFAT) using
serotype-specific monoclonal antibodies [34] and infected
supernatant was clarified by centrifugation and virus
stocks stored in 1-mL aliquots at −70°C.
RNA extraction
Viral RNA was extracted using QIAamp Viral RNA Mini
kit (Qiagen) following the manufacturer’s instructions and
stored at -70°C for DENV typing and sequencing. For the
viral 3′UTR sequencing, the RNA was extracted directly
from serum and mosquitoes macerate, previously detected
by RT-PCR. For the full genome sequencing of the
DENV-3 strain BR73354/01, the RNA was extracted from
the first passage in cell culture.
RT –PCR (Reverse transcriptase- polymerase chain
reaction)
RT—PCR for detecting and typing DENV was performed
as described previously [35].
Sequencing and phylogenetic analysis
PCR products were sequenced in both directions using
the BigDye Dideoxy Terminator sequencing kit (Applied
Biosystems). The mosquitoes’ DENV-3 full-length genome
sequence and 3′UTR sequences obtained in this study
were deposited in GenBank (www.ncbi.nlm.nih.gov) and
are described on Table 1. Sequence and similarity identity
Figure 1 Neighbor-joining phylogenetic analysis of the complete genome sequence from DENV-3 isolated from naturally infected
mosquitoes in Brazil, 2001. Black circle represent DENV-3 sequence generated in this study. Strains representative from the four genotypes
available in Genbank (www.ncbi.nlm.nih.gov) were used for the comparison, DENV-1, DENV-2 and DENV-4 strains were used as outgroup to root
the tree. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to
the branches. DENV strains used were named as follows: GenBank accession number/country/year.
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mbio.ncsu.edu/bioedit/bioedit.htmL). The multiple align-
ments were performed using CLUSTAL W (http://www.
ebi.ac.uk/clustalw/) and the phylogenetic analysis by MEGA
5 software (www.megasoftware.net), using the Neighbor-
joining method, according to the Tamura-Nei model, with a
bootstrap of 1,000 replications for the analysis of the
complete genome. For the 3′UTR analysis, the Maximum
likelihood method, according to the Kimura-2 model was
chosen as determined by the best-fit substitution model
provided by MEGA 5. Strains representative from the five
genotypes available in GenBank (www.ncbi.nlm.nih.gov)
were used for the comparison, DENV-1 (GenBank acces-
sion number #AF513110), DENV-2 (#AF489932) and
DENV-4 (# AF326573) strains were used as outgroup to
root the tree.Secondary structure analysis
The predicted secondary structures were generated
by MFOLD web server (http://mfold.rna.albany.edu/?
q=mfold/RNA-Folding-Form) with default folding para-
meters and folding predictions at 37oC on the VR from
the 3’ UTR of DENV-3.
Results and discussion
The DENV-3 was re-introduced in Latin America in 1994,
after an absence of 17 years, being initially isolated in
Panama and spreading throughout Central America
[36,37] to Caribbean [38-40] and South America
[6,28,41-43]. However, some phylogenetic studies point
to its introduction through Mexico [44] a few years
earlier [13]. This introduction caused by the genotype
III of DENV-3, originally from the Southeast Asia and
Table 2 Amino acid differences among selected Brazilian DENV-3 and strains representative of the DENV-3 genotypes,
compared to the prototype H87

































Capsid C 108 M I I I I
C112 T A A A A
prMembrane prM86 H R R R R
Envelope E81 I V V V V
E124 S P P L L L P
E132 H Y Y Y Y Y
E169 A T T T T V V V
E270 T N N N N N
E301 L T T T T S
E380 I T T
E383 K N N N
E452 I V V V V
NS1 NS184 I V
NS194 T I I I I I I
NS1139 S N N N N N N
NS1339 N S S S S
NS2A NS2A37 L F F F F
NS2A158 I M M M M
NS2A175 I V V V V V
NS2A195 T A A A A
NS2B NS2B60 V I I I I
NS2B109 I V V V V
NS3 NS3115 I T T T T
NS3452 V A A A A A
NS4A NS4A99 D E E E A
NS4B NS4B21 V I I I I
NS4B138 V I I I I











NS5229 S A A A A
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Table 2 Amino acid differences among selected Brazilian DENV-3 and strains representative of the DENV-3 genotypes,
compared to the prototype H87 (Continued)
NS5233 M R
NS5288 S N N N N
NS5365 P S S S S
NS5371 K R R R R
NS5374 E G G G G
NS5389 R K K K K
NS5422 R K K K K
NS5429 E D D D D
NS5585 K T T T T
NS5639 L P P P P
NS5763 T S S S S A S A
NS5835 DN N N N
Blank cells indicate amino acid similarities to the prototype strain H87 (GenBank accession number M93130). *STOP: stop codon.
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the occurrence of a higher number of severe and DHF
cases [37,45-47].
In Brazil, the first DENV-3 was isolated in December of
2000 in Nova Iguaçu, RJ [5] when the Ae aegypti infestation
level was 8.1% and, 58% of those mosquitoes were resistant
to temephos at that time [8,48]. Due to the role of the city
of Nova Iguaçu in dengue epidemiology, after the DENV-1
introduction in 1986 [4], field studies were conducted for
detection of DENV in field-caught vectors [8,49]. The po-
tential emergence of strains associated with severe disease
highlights the need for the surveillance of DENV in human
host and vectors, as the detection of DENV in infected
field-caught vectors is considered a useful tool for the early
prediction of epidemics and detection of new serotypes/
genotypes introductions [50,51].
The entomological surveillance performed in the first se-
mester of 2001 in Nova Iguaçu, RJ, resulted in the isolation
of three DENV-3 strains from the districts of Santa Efigênia
(BR73354/01), California (BR73356/01) and Morro Agudo
(BR73636/01) isolated from three pools (9 mosquitoes/
pool) of naturally infected Ae. aegypti females [8]. In
January 2006, one DENV-3 strain (BR81200/06) was iso-
lated from one Ae. aegypti pool composed of three females,
collected indoors in the Vargem Pequena neighborhood,
west region of RJ.
In order to access the differences among Brazilian DENV-
3, we sequenced and deposited on Genbank (FJ177308)
the entire genome sequence of one virus isolated from nat-
urally infected Ae. aegypti (BR73354/01) and compared to
the Brazilian strain 74886/02 (AY679147), isolated from the
liver of a fatal case during the DENV-3 epidemic occurred
in 2002 [31]. The nucleotide similarity was 99.3% and the
phylogeny based on the analysis of the complete coding
region characterized the Brazilian strain as belonging to
genotype III (Indian Subcontinent), Figure 1.Amino acid substitutions were observed throughout the
entire coding region, when the Brazilian DENV-3 strains
were compared to the prototype PHIL/H87/1956 and
strains representative of the other genotypes. Some substi-
tutions were exclusive to the Brazilian DENV-3 strains
analyzed (Table 2) and some were shared among the
Brazilian strains and the strain isolated from Ae. aegypti in
Taiwan in 1998 (TAIWAN/TWmosq/1998), Table 2.
Exclusive substitutions to the DENV-3 Brazilian strains
analyzed in this study were observed on the capsid, prM
and envelope genes. Besides those others observed were
also shared by other genotype III strains previously
analyzed [11].
On the NS1 gene only one residue substitution was
observed, and substitution on NS2A and NS2B were also
reported. On the NS3 gene, a substitution on only NS3115
was exclusive to the Brazilian DENV-3. On NS4B, the
same substitution was observed on positions NS4B21 and
NS4B138. However, on the NS5 gene, besides the ten sub-
stitutions exclusive to the Brazilian DENV-3, substitutions
exclusive to the Brazilian DENV-3 isolated from Ae. agypti
(BR73354/2001) were observed almost consecutively, on
NS597 and NS598. On NS5101, the substitution resulted in a
stop codon and other substitutions throughout NS5 were
also observed. Despite this, the original macerate was re-
inoculated in C6/36 cells culture and the DENV −3
infection confirmed by the presence of cytopathic effect
and a positive RT-PCR. The presence of genome-defective
DENV-3 containing either stop codons or deletions in vivo
has been reported previously [52].
Despite the use of the E gene for DENV phylogenetic
and evolutionary studies [9,12,28,53-62] due to its biological
properties and selective pressure imposed by the host im-
mune response, the role of sequences heterogeneity in
other genomic regions which includes the non-structural
genes and the genome UTRs cannot be excluded [53].
Figure 2 Multiple nucleotide sequence alignment of the Brazilian DENV-3 3′UTR from additional strains isolated from mosquitoes Ae.
aegypti (n=4) and humans (n=10) from 2001 to 2008. Dots (.) indicate identity among strains based on the Brazilian strain BR74886/02,
characterized by the 11 nucleotides insertion on the variable region (VR). Dashes (−) indicate gaps in the alignment. The 8 nucleotides deletion
characteristic to strains isolated from mosquitoes BR73354mosq/2001, BR73356mosq/2001 and from a strain isolated in human (BR74792/2002)
are marked by black squares. Eleven nucleotide insertion and conserved sequence regions (RCS2, CS2 and CS1) are gray-shadowed.
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Figure 3 (See legend on next page.)
Castro et al. Virology Journal 2013, 10:3 Page 8 of 11
http://www.virologyj.com/content/10/1/3
(See figure on previous page.)
Figure 3 On (A) the predicted secondary structure of the variable region (VR) from Brazilian DENV-3 strains isolated from humans and
mosquitoes Ae. Aegypti (nucleotides 1 to 108) presenting the 11-nucleotides insertion and compared to the prototype PHIL/87/1956
(nucleotides 1–104). On (B) the predicted secondary structures from the Brazilian strains (nucleotides 1 to108) presenting the 11-nucleotides
insertion, but with nucleotides substitutions differing from the strains on (A) and on (C) the structures from the sequences (nucleotides 1 to 100)
with the 8-nucleotides deletion.
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secondary structures of the 5′ and 3′UTR of flaviviruses
play an important role in viral replication and differences in
these regions may influence viral virulence [24,26,27,63].
Mutations and deletions within these regions may alter
infectivity and reduce efficiency of viral replication
[22,23]. Furthermore, the domain I from the DENV
3′UTR is considered the most variable region (VR) from
the 3′UTR [18] and can serve as a good marker for
DENV evolution [19-21].
The analysis of the 3′UTR of the strain BR73354/01
genome showed an 8- nucleotides deletion within the
11-nucleotides insertion on the VR, previously observed
for the Brazilian DENV-3 strain isolated from humans [31]
and common to genotype III DENV-3 strains from the
Latin America/Caribbean and Sri Lanka regions [27,64].
Nucleotides substitutions exclusive to the BR73354/01 were
observed on positions 10,383 and 10,391 from the 3′UTR.
One substitution on the RCS2 and one on the CS2 were
shared by all Brazilian DENV-3 when compared to the
prototype.
We additionally analyzed and deposited on GenBank the
3′UTR sequences from other three DENV-3 strains iso-
lated from naturally infected Ae. aegypti isolated in 2001
and 2006 in RJ (BR73356/01, BR73636/01 and BR81200/
06) and from ten DENV-3 isolated from humans from
2001 to 2008. The strain BR73356/01 presented the same
8-nucleotides deletion observed for the strain BR73354/01.
However, the other two strains also isolated from mosqui-
toes in RJ (BR73636/01 and BR81200/06) presented the
11-nucleotides insertion common to the human strains.
The analysis of the 3′UTR from DENV-3 isolates from
humans showed that nine out of ten strains also presented
the 11-nucleotides previously described. However, one of
the strains isolated in Rio de Janeiro in 2002 (BR74792/02)
showed the same 8-nucleotides deletion observed on the
mosquito strains (Figure 2). Previous studies have shown
deletions and nucleotide variations in the VR within a
same serotype [28,29]. Despite those observations, it was
also shown a high conservation on the 3′UTR RCS2, CS1
and CS2 conserved regions (Figure 2, gray-shadowed areas)
among all the Brazilian strains analyzed. This was quite
expected as domain II is of moderate conservation and do-
main III, the most conserved region of all [18].Therefore,
we focused on the VR of the 3′UTR, aiming to better
characterize those mutations by predicting the secondary
structures of that region. Not all strains presenting the 11-nucleotides insertion were similar in structure (Figure 3A
and 3B). In fact, despite the 11-nucleotides insertion, the
strain BR72/2008 presented a unique secondary structure
(Figure 3B). The only difference from the latter is a nucleo-
tide substitution (G →A) on the 11-nucleotides insertion
region, when compared to all other Brazilian sequences
analyzed (Figure 2). The strain BR80996/2006, also showed
a unique secondary structure due to the nucleotides substi-
tution presented in the VR, despite the presence of the in-
sertion shared with the other strains. The slight difference
presented by the strain BR83904/2007, was due to a substi-
tution (C→T) exclusive to this sequence. Furthermore, all
three sequences with the 8-nucleotides deletion (BR73354
mosq/2001, BR73356mosq/2001 and BR74792/2002) pre-
sented the same secondary structure (Figure 3C).
Phylogenetic studies based on the 5′and 3′UTR have
shown to be very useful for molecular epidemiological stud-
ies [19,21,27,28,65]. The Maximum-Likelihood phylogen-
etic tree of Brazilian DENV-3 strains isolates from naturally
infected Ae. aegypti mosquitoes and humans based on the
3′UTR sequence analysis places those strains as belonging
to genotype III, corroborating the findings of the full-length
genome analysis (data not shown).
Conclusions
Here, we analyzed the coding region and the 3′UTR of
DENV-3 from both human host and mosquitoes and
described insertions, deletions and a substitution leading to
stop codon formation. The majority of DENV-3 in this
study was characterized by the 11-nucleotide insertion in
the 3′UTR, despite the observation of strains carrying the
8-nucleotide deletion. In spite the presence of distinct viral
variants, it is suggested that the major variant is transmit-
ted. However, how those distinct viral populations are
maintained or transmitted is not fully understood,
therefore the availability of viruses isolated from both
hosts are crucial for the better comprehension of the
vector-virus-human host interactions and for quasispecies
investigations. Furthermore, the analysis of those distinct
viral populations in experimentally infected mosquitoes
may help to elucidate those observations.
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